Amy McBride Wendell
CIK: 0001400568
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Aug 11, 2026AXGN
Axogen, Inc.
Sale(S)Direct13.4K shares at avg. $48.42$647K - Aug 11, 2026AXGN
Axogen, Inc.
Exercise(M)Direct13.4K shares at avg. $14.85$198K - Jun 24, 2026AXGN
Axogen, Inc.
Award(A)DirectRestricted Stock Units
4.4K shares- - Jun 19, 2026AXGN
Axogen, Inc.
Exercise(M)Direct14.2K shares- - May 15, 2026SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.3K shares- - May 8, 2026AXGN
Axogen, Inc.
Sale(S)Direct1.6K shares at avg. $42.60$70K - May 8, 2026AXGN
Axogen, Inc.
Exercise(M)Direct1.6K shares at avg. $14.85$24K - May 5, 2026BAX
BAXTER INTERNATIONAL INC
Award(A)Direct12.8K shares- - Apr 30, 2026SOLV
Solventum Corp
Exercise(M)Direct3.4K shares- - Apr 7, 2026HOLX
HOLOGIC INC
Disposition(D)Direct25.8K shares- - Mar 27, 2026SOLV
Solventum Corp
Exercise(M)Direct2K shares- - Mar 10, 2026SOLV
Solventum Corp
Purchase(P)Direct1.5K shares at avg. $68.03$100K - Feb 26, 2026HOLX
HOLOGIC INC
Award(A)Direct3.2K shares- - Dec 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct5K shares at avg. $8.95$45K - Dec 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct20.4K shares at avg. $6.30$129K - Dec 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct18.2K shares at avg. $7.04$128K - Dec 16, 2025AXGN
Axogen, Inc.
Sale(S)Direct5K shares at avg. $29.31$147K - Dec 16, 2025AXGN
Axogen, Inc.
Sale(S)Direct20.4K shares at avg. $29.31$599K - Dec 16, 2025AXGN
Axogen, Inc.
Sale(S)Direct18.2K shares at avg. $29.31$535K - Jun 19, 2025AXGN
Axogen, Inc.
Award(A)DirectRestricted Stock Units
14.2K shares- - Jun 9, 2025AXGN
Axogen, Inc.
Sale(S)Direct4.1K shares at avg. $10.61$43K - May 13, 2025SOLV
Solventum Corp
Exercise(M)Direct3.6K shares- - May 6, 2025BAX
BAXTER INTERNATIONAL INC
Award(A)Direct7.2K shares- - Apr 30, 2025SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.4K shares- - Mar 3, 2025AXGN
Axogen, Inc.
Sale(S)Direct5K shares at avg. $20.02$100K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 11, 2026 |  AXGN Axogen, Inc. | Sale(S) | 13,353 | $48.42 | $646,592 | Direct |
| Aug 11, 2026 | AXGN Axogen, Inc. | Exercise(M) | 13,353 | $14.85 | $198,292 | Direct |
| Jun 24, 2026 | AXGN Axogen, Inc. | Award(A) Restricted Stock Units | 4,392 | - | - | Direct |
| Jun 19, 2026 | AXGN Axogen, Inc. | Exercise(M) | 14,150 | - | $0 | Direct |
| May 15, 2026 |  SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,300 | - | - | Direct |
| May 8, 2026 | AXGN Axogen, Inc. | Sale(S) | 1,647 | $42.60 | $70,162 | Direct |
| May 8, 2026 | AXGN Axogen, Inc. | Exercise(M) | 1,647 | $14.85 | $24,458 | Direct |
| May 5, 2026 |  BAX BAXTER INTERNATIONAL INC | Award(A) | 12,836 | - | $0 | Direct |
| Apr 30, 2026 | SOLV Solventum Corp | Exercise(M) | 3,403 | - | $0 | Direct |
| Apr 7, 2026 |  HOLX HOLOGIC INC | Disposition(D) | 25,784 | - | $0 | Direct |
| Mar 27, 2026 | SOLV Solventum Corp | Exercise(M) | 1,980 | - | $0 | Direct |
| Mar 10, 2026 | SOLV Solventum Corp | Purchase(P) | 1,475 | $68.03 | $100,344 | Direct |
| Feb 26, 2026 | HOLX HOLOGIC INC | Award(A) | 3,190 | - | $0 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 5,000 | $8.95 | $44,750 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 20,436 | $6.30 | $128,747 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 18,248 | $7.04 | $128,466 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Sale(S) | 5,000 | $29.31 | $146,560 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Sale(S) | 20,436 | $29.31 | $599,020 | Direct |
| Dec 16, 2025 | AXGN Axogen, Inc. | Sale(S) | 18,248 | $29.31 | $534,885 | Direct |
| Jun 19, 2025 | AXGN Axogen, Inc. | Award(A) Restricted Stock Units | 14,150 | - | - | Direct |
| Jun 9, 2025 | AXGN Axogen, Inc. | Sale(S) | 4,073 | $10.61 | $43,215 | Direct |
| May 13, 2025 | SOLV Solventum Corp | Exercise(M) | 3,564 | - | - | Direct |
| May 6, 2025 | BAX BAXTER INTERNATIONAL INC | Award(A) | 7,183 | - | - | Direct |
| Apr 30, 2025 | SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,403 | - | - | Direct |
| Mar 3, 2025 | AXGN Axogen, Inc. | Sale(S) | 5,000 | $20.02 | $100,100 | Direct |
1-25 of 27 transactions
About Wendell Amy McBride
Wendell Amy McBride (SEC CIK 0001400568) files insider reports with the SEC as Director of Axogen, Inc. (AXGN), Director of Solventum Corp (SOLV) and Director of BAXTER INTERNATIONAL INC (BAX). Signal8 also holds filings tied to 1 other company.
Signal8 holds 20 ownership filings by Wendell Amy McBride, all Form 4s, filed between Sep 4, 2024 and Aug 12, 2026. Those filings report 27 transactions, from Sep 1, 2024 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wendell Amy McBride's filings is in ALACHUA, FL.
Recent filings by Wendell Amy McBride
- Aug 11, 2026: Open-market sale of AXGN shares (Form 4, code S).
- Aug 11, 2026: Option exercise of AXGN shares (Form 4, code M).
- Jun 24, 2026: Grant or award of AXGN derivative securities (Form 4, code A).
- Jun 19, 2026: Option exercise of AXGN shares (Form 4, code M).
- May 15, 2026: Grant or award of SOLV derivative securities (Form 4, code A).
Other insiders filing for Axogen, Inc. (AXGN)
- TYNDALL JOSEPH A., Director
- Began Marc A, EVP & General Counsel
- Weiler Kathy Johnson, Director
- Burke William P. Mr., Director
- JOHNSON JOHN, Director
- Levine Alan M, Director